RxDoctor Payments Data

Frank Williams, OD

Optometrist · Kearney, NENPI 1720180425

Payments from drug & device makers

$283in general payments, 2019–2025

Across 13 payments — averaging $21.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Oyster Point Pharma, Inc.$84
  • Dompe US, Inc.$69
  • Glaukos Corporation$30
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$23
  • Bausch & Lomb Americas Inc.$20
  • Ocular Therapeutix, Inc.$19
  • plus $36 from 2 others

What the payments were for

  • Food & beverage$283100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$283 in reported general payments places this provider in the 35th percentile of 383 optometrist providers in Nebraska.

See all optometrist providers in Nebraska

Medicare billing

Part B allowed, 2024
$240,150
Medicare patients
1,443
Services billed
2,807

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RestasisCyclosporine39$27,676
LumiganBimatoprost34$14,893
XiidraLifitegrast14$14,484
RocklatanNetarsudil Mesylat/Latanoprost30$9,819
Cyclosporine22$9,648
Latanoprost781$8,763
Prednisolone Acetate110$3,936
TobradexTobramycin/Dexamethasone12$2,953
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat130$2,669
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol13$2,259
Dorzolamide Hcl99$1,570
Timolol Maleate105$1,394
ValacyclovirValacyclovir Hcl49$1,342
Dorzolamide-TimololDorzolamide/Timolol/Pf14$1,160
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha78$1,024

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieRestasis, Lumigan$18$42,56973 claims
Bausch & Lomb Americas Inc.Xiidra$20$14,48414 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 383 optometrist providers in Nebraska.

Other optometrist in Kearney

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →